mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.9 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |